Market revenue in 2024 | USD 69.4 million |
Market revenue in 2030 | USD 122.3 million |
Growth rate | 9.9% (CAGR from 2024 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.75% in 2024. Horizon Databook has segmented the Sweden oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden, with its robust biotechnology and life sciences sectors, plays a significant role in the global oligonucleotide synthesis market. Sweden has a strong tradition of scientific research, and oligonucleotides are crucial in biomedical research.
Moreover, researchers use synthetic oligonucleotides for gene expression studies, functional genomics, and other molecular biology applications. Furthermore, strategic initiatives such as mergers, acquisitions, collaborations, and expansions are expected to support market growth over the forecast period.
For instance, in October 2021, Biotage acquired ATDBio Ltd., a UK-based company. This acquisition significantly strengthened Biotage’s position in the oligonucleotide market.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into Sweden oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account